FULL POSTER SESSION ABSTRACTS17. Can-Hsp31 is important for Candida albicans growth and survival. S. Hasim, N. Ahmad hussin, K. Nickerson. Biological Science, Univesity of NebraskaLincoln, Lincoln, NE.Candida albicans is an opportunistic pathogen that is able to grow as budding yeast, pseudohyphae, and hyphae. A key feature of C. albicans is its abilityto grow in diverse microenvironments and develop complex and highly efficient responses in order to survive within the host environment. The C. albicansHsp31 (ORF19.251) gene encodes a protein that belongs to the DJ1/PfpI family with close homology to other fungal Hsp31-like proteins. Despite intensivestudy, the function of these fungal Hsp31 proteins is unknown. The crystal structure of Can-Hsp31 was solved to 1.6 Å resolution. Its structure is similar tothose of the E.coli and S. cerevisiae Hsp31 proteins except that Can-Hsp31 is a monomer in the crystal while all other known homologues are dimers. Inthis report, we show that the C. albicans’ Hsp31 is important for growth and survival under various stress conditions.18. Influence of N-glycans on a-/b-(1,3)-glucanase and a-(1,4)-amylase from Paracoccidioides brasiliensis yeast cells. Fausto Bruno Dos Reis Almeida 1 ,Valdirene Neves Monteiro 2 , Roberto Nascimento Silva 3 , Maria Cristina Roque-Barreira 1 . 1) Cellular and Molecular Biology, University of Sao Paulo, RibeiraoPreto, Brazil; 2) University of Goias, Anapolis, Brazil; 3) Biochemistry and Immunology, University of Sao Paulo, Ribeirao Preto, Brazil.Paracoccidioides brasiliensis (Pb) is a temperature-dependent dimorphic fungus and the causative agent of paracoccidioidomycosis, the most prevalentsystemic mycosis in Latin America. The cell wall (CW) of Pb is a network of glycoproteins and polysaccharides, such as chitin, glucan and N-glycosylatedproteins, that may perform several functions. N-glycans are involved in glycoprotein folding, intracellular transport, secretion, and protection fromproteolytic degradation. Our group has been describing the role of N-acetylglucosaminidase (NAGase) in fungal growth, exerted through participation inchitin metabolism and CW remodeling. In addition, by assessing yeast cells cultured with tunicamycin (TM), we determined that N-glycans play importantroles in growth and morphogenesis of Pb yeasts and are required for the fungal NAGase function. In this study, we verify the influence of TM-mediatedinhibition of N-linked glycosylation on a- and b-(1,3)-glucanase, as well as the a-(1,4)-amylase, produced by Pb yeast cells. The treatment of Pb with 15 mgTM/ml did not interfere with a- and b-(1,3)-glucanase production, secretion or on enzyme structure. The absence of N-glycans did not affect pH optimum(5.5) or temperature optimum (45 °C). Moreover, the fully- and under-glycosylated forms of the enzymes had similar Km and Vmax values. On the otherhand, a-(1,4)-amylase demonstrated lower enzymatic activity when underglycosylated, although no difference was detected between the pH andtemperature optimums of the two forms. Our results corroborates with the recent observation that a-(1,4)-amylase from Pb plays important roles on thefungal CW a-(1,3)-glucan biosynthesis. However, interestingly the Pbaglucan gene, that encode to a-(1,3)-glucanase, had its expression increased by 2.5-fold in Pb cells treated with TM when evaluated by qRT-PCR, suggesting an indirect influence of TM on CW glucan synthesis. Genes encoding to UPR(Unfolding Protein Response) and CW synthesis showed their expression increased, corroborating with our data. Analyses investigating the effect of N-glycans in mycelium cells are under way in our laboratory. Our results suggest that N-glycans do not play direct effect on a- and b-(1,3)-glucanase activityproduced by yeasts cells but indirect effect by affecting a-(1,4)-amylase.19. Cell wall structure and biosynthesis in oomycetes and true fungi: a comparative analysis. Vincent Bulone. Sch Biotech, Royal Inst Biotech (KTH),Stockholm, Sweden.Cell wall polysaccharides play a central role in vital processes like the morphogenesis and growth of eukaryotic micro-organisms. Thus, the enzymesresponsible for their biosynthesis represent potential targets of drugs that can be used to control diseases provoked by pathogenic species. One of themost important features that distinguish oomycetes from true fungi is their specific cell wall composition. The cell wall of oomycetes essentially consists of(1®3)-b-glucans, (1®6)-b-glucans and cellulose whereas chitin, a key cell wall component of fungi, occurs in minute amounts in the walls of some oomycetespecies only. Thus, the cell walls of oomycetes share structural features with both plants [cellulose; (1®3)-b-glucans] and true fungi [(1®3)-b-glucans, (1®6)-b-glucans and chitin in some cases]. However, as opposed to the fungal and plant carbohydrate synthases, the oomycete enzymes exhibit specific domaincompositions that may reflect polyfunctionality. In addition to summarizing the major structural differences between oomycete and fungal cell walls, thispresentation will compare the specific properties of the oomycete carbohydrate synthases with the properties of their fungal and plant counterparts, withparticular emphasis on chitin, cellulose and (1®3)-b-glucan synthases. The significance of the association of these carbohydrate synthases with membranemicrodomains similar to lipid rafts in animal cells will be discussed. In addition, distinguishing structural features within the oomycete class will behighlighted with the description of our recent classification of oomycete cell walls in three different major types. Genomic and proteomic analyses ofselected oomycete and fungal species will be correlated with their cell wall structural features and the corresponding biosynthetic pathways.20. Investigating the function of a putative chitin synthase from Phytophthora infestans. Stefan Klinter, Laura Grenville-Briggs, Hugo Mélida, VincentBulone. School of Biotechnology, Division of Glycoscience, Royal Institute of Technology (KTH), Stockholm, Sweden.The oomycete Phytophthora infestans is a plant pathogen that causes potato late blight, a devastating disease associated with tremendous economiclosses. In contrast to true fungi, oomycetes are traditionally described as cellulosic micro-organisms. Indeed, in addition to other b-glucans, cellulose is amajor polysaccharide in the mycelial cell wall of P. infestans while chitin and other N-acetylglucosamine (GlcNAc)-based carbohydrates are absent fromhyphal walls. However, a putative chitin synthase gene (chs) is present in the genome. Bioinformatic analysis identified the C-terminal region of thepredicted protein to be highly similar to glycosyltransferase family 2 proteins, such as fungal chitin synthases, while the N-terminal domain is moredivergent. Orthologous putative chs genes are present in all sequenced oomycete genomes and phylogenetic analysis shows the oomycete gene productsform a new clade separate from the fungal lineage. The P. infestans chs transcript is highly abundant in older mycelium. However, no chitin synthaseactivity was detectable in microsomal fractions assayed with radioactively-labeled UDP-GlcNAc, the natural substrate of chitin synthase. Suprisingly, hyphalgrowth was severely retarded in the presence of low micromolar concentrations of the chitin synthase inhibitor nikkomycin Z, a structural analogue ofUDP-GlcNAc. Microscopic analysis of nikkomycin Z-treated hyphae revealed frequent tip swelling and bursting. Similarly, transient RNA-mediated silencingof the chs gene resulted in severely reduced growth, and hyphae showed a hyper-branched morphology with swollen tips. As a first step to determine theprecise function of the P. infestans chs gene, we have cloned and expressed it in Saccharomyces cerevisiae.21. Deciphering cell wall structure and biosynthesis in oomycetes using carbohydrate analyses and plasma membrane proteomics. Hugo Melida 1 ,Vaibhav Srivastava 1 , Erik Malm 1 , J. Vladimir Sandoval-Sierra 2 , Javier Dieguez-Uribeondo 2 , Vincent Bulone 1 . 1) Division of Glycoscience, Royal Institute ofTechnology (KTH), Stockholm, Sweden; 2) Mycology Department, Royal Botanical Garden (CSIC), Madrid, Spain.Some oomycete species are severe pathogens of economically important animals or plants. Proteins involved in cell wall metabolism represent excellenttargets for disease control. The objective of our work was to determine the fine cell wall polysaccharide composition of selected species and identify thecorresponding membrane-bound biosynthetic enzymes and other proteins involved in cell wall remodeling. In the first instance, we performed a detailedcarbohydrate analysis of the mycelial cell walls of 11 oomycete species from 2 major orders, the Saprolegniales and Peronosporales. We then selected thefish pathogen Saprolegnia parasitica for in-depth proteomics analysis. Our results indicate the existence of 3 clearly different cell wall types. This126
FULL POSTER SESSION ABSTRACTSbiochemical distinction is in agreement with the taxonomic grouping based on molecular markers of the species studied. The 3 cell wall types aredistinguishable by their cellulose content and the fine structure of their 1,3-b-glucans. Furthermore, unique features were found in each case. Type I cellwalls (e.g. Phytophthora) are devoid of N-acetylglucosamine (GlcNAc) but contain glucuronic acid and mannose; type II (e.g. Achlya, Dictyuchus,Leptolegnia and Saprolegnia) contain up to 5% GlcNAc and residues indicative of cross-links between cellulose and 1,3-b-glucans; type III (e.g.Aphanomyces) are characterized by the highest GlcNAc content (> 5%) and the occurrence of unusual carbohydrates that consist of 1,6-linked GlcNAcresidues. Analysis of the recently sequenced genome of S. parasitica was combined with quantitative mass spectrometry-based proteomics (label-free andiTRAQ) to characterize the plasma membrane proteome of hyphal cells. This strategy allowed us to experimentally identify a total of 677 plasmamembrane proteins, including several key cell wall polysaccharide synthases, e.g. cellulose, 1,3-b-glucan and chitin synthases, some of which arespecifically enriched in plasma membrane microdomains similar to lipid rafts in animal cells.22. Identification and characterization of the chitin synthase genes in the fish pathogen Saprolegnia parasitica. Elzbieta Rzeszutek, Sara Diaz, VincentBulone. School of Biotechnology, Division of Glycoscience, Royal Institute of Technology (KTH), Stockholm, Sweden.The oomycete Saprolegnia parasitica is a fungus-like microorganism responsible for fish diseases and huge losses in aquaculture. The analysis of the cellwall composition of the microorganism and the characterization of key enzymes involved in cell wall biosynthesis may facilitate the identification of newtarget proteins for disease control. The cell wall of hyphal cells of S. parasitica consists mainly of cellulose, b-(1®3)- and b-(1®6) glucans, whereas chitin ispresent in minute amounts only. The main objective of this work was to test the effect of nikkomycin Z, a competitive inhibitor of chitin synthase (CHS), onthe growth of S. parasitica. Genome mining allowed the identification of six different putative chs genes whose actual occurrence in the genomic DNA ofthe microorganism was confirmed by Southern blot analysis. The expression of the chs genes in the mycelium was analyzed using Real-Time PCR. Theresults revealed a higher expression level of four of the six genes while the two others exhibited undetectable levels of expression in the mycelium. Thissuggests that the latter genes are most likely primarily involved in chitin formation at a different developmental stage. The presence of nikkomycin Zincreased the expression level of one of the genes, chs3, suggesting that the corresponding product is involved in forming the abnormal branchingstructures in the hyphae exposed to the inhibitor. The capacity of the mycelium to synthesize chitin was demonstrated by performing in vitro synthesisreactions using cell-free extracts. CHS activity was measured in intact cell membranes as well as in detergent-extract of membranes. The polysaccharidesynthesized in vitro was characterized by enzymatic hydrolysis with a specific chitinase. Our data demonstrate that CHS represent promising targets ofanti-oomycete drugs, even though the amount of chitin in the cell wall of S. parasitica does not exceed a few percent.23. Role of Ccr4-mediated mRNA turnover in nucleotide/deoxynucleotide homeostasis and Amphotericin B susceptibility in Cryptococcus neoformans.D. Banerjee, J. Panepinto. Department of Microbiology and Immunology.University at Buffalo, SUNY, Buffalo, NY.Ccr4 mediated deadenylation is the first and rate limiting step in eukaryotic mRNA decay. The end products of mRNA degradation are nucleosidemonophosphates (NMPs) which are then converted to nucleotides (NDPs and NTPs) and deoxynucleotides (dNTPs) in downstream reactions. A C.neoformans degradation deficient ccr4D mutant exhibits replication stress sensitivity and stabilizes ribosomal protein (RP) transcripts during carbonstarvation, suggesting that ccr4D mutant is deficient in intracellular nucleotide stores. Analysis of gene expression showed an up-regulation of thenucleotide synthesis machinery in ccr4D mutant even under unstressed conditions consistent with our hypothesis. Time-kill assays in the presence ofmycophenolic acid (MPA), an inhibitor of guanine nucleotide de novo synthesis, showed a reduction in the viability of ccr4D mutant that was rescued bythe addition of exogenous guanine, suggesting that the salvage pathway is indeed functional. These results suggest that the degradation of mRNAtranscripts lead to the production of NMPs that replenish NTP/dNTP pools in C. neoformans during starvation stress. The fungicidal efficacy ofAmphotericin B (AmpB) is enhanced by the use of Flucytosine, a pyrimidine analog, suggesting a synergy between AmpB and nucleotide deficiency forcryptococcosis treatment. We compared the sensitivity of wild type (H99), ccr4D mutant and H99-FOA strain (de novo mutant of pyrimidine synthesis) to acombination of AmpB and NTP/dNTP inhibitors. Both mutants exhibited higher sensitivity to AmpB which was unaltered by additional stressors. H99exhibited an increased sensitivity to the combination of AmpB with both NTP and dNTP inhibitors, compared to AmpB alone. Taken together, these datasuggest that nucleotide depletion, either by a pharmacologic agent or a mutation predisposes the cells to enhanced AmpB mediated cell death.Thus ouroverall hypothesis is that Ccr4 mediated mRNA turnover results in the maintenance of intracellular NTP/dNTP pools to promote growth, virulence, stresstolerance and also modulates Amp B susceptibility in C. neoformans. Results from these studies will identify a novel role of the mRNA degradationmachinery in C. neoformans pathogenesis and stress tolerance and also aid in the identification of new anti-cryptococcal drug targets.24. WITHDRAWN25. Blue light induce Cordyceps militaris fruiting body formation and cordycepin production. Chun-Hsiang Yang 1 , Shun-Kuo Sun 2 , Su-Der Chen 1 . 1)Biotechnology and Animal science, National Ilan University, Ilan, Taiwan; 2) Bionin Biotechnology, INC.Cordyceps militaris is a very important fungal medicine in Chinese. The fruiting body of Cordyceps militaris has been described by many researcherscontaining biological activies, such as being able to inhibit cell proliferation, provide anti-ageing activity, inhibit protein synthesis and lowing cardiovascularrisk. Cordyceps militaris has been grown and harvested by many Chinese people, and were able to obtain its fruiting body with orange collar and barshape. Solid cultivation as carried out 3 to 4 days after mycelium seeding from liquid culture, then fruiting body formation can been induced by light( 12hours per day). In this research, the light-inducing mechanism of fruiting body formation was studied. The results showed the fruiting body was induced byblue light but not red light. Cordycepin, the most important compound with medical potential of Cordyceps militaris, is mainly stored in fruiting body,rather than in mycelium from liquid culture. Cordycepin production depends on various factors, including: wave length of light and culture in solid orliquid. The results also showed the relationship between cordycepin production and blue light sensor in Cordyceps militaris, which might contain LOVdomain.26. Insight into alkaloid diversity of the epichloae, protective symbionts of grasses. Carolyn A. Young 1 , Nikki D. Charlton 1 , Johanna E. Takach 1 , Ginger A.Swoboda 1 , Bradley A. Hall 1 , Kelly D. Craven 2 , Christopher L. Schardl 3 . 1) Forage Improvement Division, The Samuel Roberts Noble Foundation, Ardmore,OK; 2) Plant Biology Division, The Samuel Roberts Noble Foundation, Ardmore, OK; 3) Plant Pathology, University of Kentucky, Lexington, KY.Cool season grasses from the subfamily Pooideae often form symbiotic associations with fungal endophytes known collectively as the epichloae (Epichloëand Neotyphodium species). The epichloae consist of both sexual (nonhybrid) and asexual (hybrid and nonhybrid) species that can produce the bioactiveanti-herbivore compounds, ergot alkaloids, indole-diterpenes, lolines and peramine. Epichloae can exhibit considerable chemotypic diversity within thepathways of these four alkaloid classes as well as the combination of alkaloids that can be produced by an individual, and as such, may equate to fitnessbenefits for the host. The current genome sequencing efforts, whereby at least 10 epichloae have been sequenced, now allows us to develop simple<strong>27th</strong> <strong>Fungal</strong> <strong>Genetics</strong> <strong>Conference</strong> | 127
- Page 1:
Asilomar Conference GroundsMarch 12
- Page 7 and 8:
SCHEDULE OF EVENTSFriday, March 157
- Page 10 and 11:
EXHIBITSThe following companies hav
- Page 12 and 13:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 14:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 17 and 18:
CONCURRENT SESSIONS SCHEDULESThursd
- Page 19:
CONCURRENT SESSIONS SCHEDULESFriday
- Page 22 and 23:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 24:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 27 and 28:
PLENARY SESSION ABSTRACTSThursday,
- Page 29 and 30:
PLENARY SESSION ABSTRACTSFriday, Ma
- Page 31 and 32:
PLENARY SESSION ABSTRACTSSaturday,
- Page 33 and 34:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 35 and 36:
CONCURRENT SESSION ABSTRACTSUnravel
- Page 37 and 38:
CONCURRENT SESSION ABSTRACTSSynergi
- Page 39 and 40:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 41 and 42:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 43 and 44:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 45 and 46:
CONCURRENT SESSION ABSTRACTSA draft
- Page 47 and 48:
CONCURRENT SESSION ABSTRACTSRegulat
- Page 49 and 50:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 51 and 52:
CONCURRENT SESSION ABSTRACTSThursda
- Page 53 and 54:
CONCURRENT SESSION ABSTRACTSThursda
- Page 55 and 56:
CONCURRENT SESSION ABSTRACTSThursda
- Page 57 and 58:
CONCURRENT SESSION ABSTRACTSThursda
- Page 59 and 60:
CONCURRENT SESSION ABSTRACTSThursda
- Page 61 and 62:
CONCURRENT SESSION ABSTRACTSThe mut
- Page 63 and 64:
CONCURRENT SESSION ABSTRACTSInnate
- Page 65 and 66:
CONCURRENT SESSION ABSTRACTSThursda
- Page 67 and 68:
CONCURRENT SESSION ABSTRACTSGenome-
- Page 69 and 70:
CONCURRENT SESSION ABSTRACTSIdentif
- Page 71 and 72:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 73 and 74:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 75 and 76:
CONCURRENT SESSION ABSTRACTSThe Scl
- Page 77 and 78:
CONCURRENT SESSION ABSTRACTSThe rol
- Page 79 and 80: CONCURRENT SESSION ABSTRACTSFriday,
- Page 81 and 82: CONCURRENT SESSION ABSTRACTSCompari
- Page 83 and 84: CONCURRENT SESSION ABSTRACTSNovel t
- Page 85 and 86: CONCURRENT SESSION ABSTRACTSFriday,
- Page 87 and 88: CONCURRENT SESSION ABSTRACTSEffect
- Page 89 and 90: CONCURRENT SESSION ABSTRACTSCommon
- Page 91 and 92: CONCURRENT SESSION ABSTRACTSSaturda
- Page 93 and 94: CONCURRENT SESSION ABSTRACTSSeconda
- Page 95 and 96: CONCURRENT SESSION ABSTRACTSSheddin
- Page 97 and 98: CONCURRENT SESSION ABSTRACTSSaturda
- Page 99 and 100: CONCURRENT SESSION ABSTRACTSSaturda
- Page 101 and 102: CONCURRENT SESSION ABSTRACTSSaturda
- Page 103 and 104: CONCURRENT SESSION ABSTRACTSprocess
- Page 105 and 106: CONCURRENT SESSION ABSTRACTSSpecifi
- Page 107 and 108: LISTING OF ALL POSTER ABSTRACTSBioc
- Page 109 and 110: LISTING OF ALL POSTER ABSTRACTS81.
- Page 111 and 112: LISTING OF ALL POSTER ABSTRACTS160.
- Page 113 and 114: LISTING OF ALL POSTER ABSTRACTS239.
- Page 115 and 116: LISTING OF ALL POSTER ABSTRACTS322.
- Page 117 and 118: LISTING OF ALL POSTER ABSTRACTS401.
- Page 119 and 120: LISTING OF ALL POSTER ABSTRACTSmedi
- Page 121 and 122: LISTING OF ALL POSTER ABSTRACTS558.
- Page 123 and 124: LISTING OF ALL POSTER ABSTRACTS640.
- Page 125 and 126: LISTING OF ALL POSTER ABSTRACTS723.
- Page 127 and 128: FULL POSTER SESSION ABSTRACTS5. Cha
- Page 129: FULL POSTER SESSION ABSTRACTS13. In
- Page 133 and 134: FULL POSTER SESSION ABSTRACTS30. Me
- Page 135 and 136: FULL POSTER SESSION ABSTRACTS38. Me
- Page 137 and 138: FULL POSTER SESSION ABSTRACTSidenti
- Page 139 and 140: FULL POSTER SESSION ABSTRACTSsecret
- Page 141 and 142: FULL POSTER SESSION ABSTRACTSinvolv
- Page 143 and 144: FULL POSTER SESSION ABSTRACTSdiploi
- Page 145 and 146: FULL POSTER SESSION ABSTRACTSSaccha
- Page 147 and 148: FULL POSTER SESSION ABSTRACTSresist
- Page 149 and 150: FULL POSTER SESSION ABSTRACTS96. Ce
- Page 151 and 152: FULL POSTER SESSION ABSTRACTS104. M
- Page 153 and 154: FULL POSTER SESSION ABSTRACTScan ex
- Page 155 and 156: FULL POSTER SESSION ABSTRACTSturgor
- Page 157 and 158: FULL POSTER SESSION ABSTRACTSlike p
- Page 159 and 160: FULL POSTER SESSION ABSTRACTSIndoor
- Page 161 and 162: FULL POSTER SESSION ABSTRACTSlength
- Page 163 and 164: FULL POSTER SESSION ABSTRACTSA scre
- Page 165 and 166: FULL POSTER SESSION ABSTRACTSthen q
- Page 167 and 168: FULL POSTER SESSION ABSTRACTS170. S
- Page 169 and 170: FULL POSTER SESSION ABSTRACTSof sup
- Page 171 and 172: FULL POSTER SESSION ABSTRACTSis fzo
- Page 173 and 174: FULL POSTER SESSION ABSTRACTSgrowth
- Page 175 and 176: FULL POSTER SESSION ABSTRACTSSeq da
- Page 177 and 178: FULL POSTER SESSION ABSTRACTS212. T
- Page 179 and 180: FULL POSTER SESSION ABSTRACTSCompar
- Page 181 and 182:
FULL POSTER SESSION ABSTRACTSmore g
- Page 183 and 184:
FULL POSTER SESSION ABSTRACTSmolecu
- Page 185 and 186:
FULL POSTER SESSION ABSTRACTSunexpe
- Page 187 and 188:
FULL POSTER SESSION ABSTRACTSrapid
- Page 189 and 190:
FULL POSTER SESSION ABSTRACTS260. T
- Page 191 and 192:
FULL POSTER SESSION ABSTRACTSFusari
- Page 193 and 194:
FULL POSTER SESSION ABSTRACTSScienc
- Page 195 and 196:
FULL POSTER SESSION ABSTRACTS286. G
- Page 197 and 198:
FULL POSTER SESSION ABSTRACTSincomp
- Page 199 and 200:
FULL POSTER SESSION ABSTRACTSfound
- Page 201 and 202:
FULL POSTER SESSION ABSTRACTS312. I
- Page 203 and 204:
FULL POSTER SESSION ABSTRACTSall th
- Page 205 and 206:
FULL POSTER SESSION ABSTRACTSPia La
- Page 207 and 208:
FULL POSTER SESSION ABSTRACTS335. A
- Page 209 and 210:
FULL POSTER SESSION ABSTRACTS342. F
- Page 211 and 212:
FULL POSTER SESSION ABSTRACTSThis i
- Page 213 and 214:
FULL POSTER SESSION ABSTRACTSJacobs
- Page 215 and 216:
FULL POSTER SESSION ABSTRACTScalciu
- Page 217 and 218:
FULL POSTER SESSION ABSTRACTSThe ab
- Page 219 and 220:
FULL POSTER SESSION ABSTRACTSexpres
- Page 221 and 222:
FULL POSTER SESSION ABSTRACTS394. F
- Page 223 and 224:
FULL POSTER SESSION ABSTRACTS398. U
- Page 225 and 226:
FULL POSTER SESSION ABSTRACTSthe id
- Page 227 and 228:
FULL POSTER SESSION ABSTRACTS415. A
- Page 229 and 230:
FULL POSTER SESSION ABSTRACTSAcuM b
- Page 231 and 232:
FULL POSTER SESSION ABSTRACTSdiverg
- Page 233 and 234:
FULL POSTER SESSION ABSTRACTSBck1 f
- Page 235 and 236:
FULL POSTER SESSION ABSTRACTSin the
- Page 237 and 238:
FULL POSTER SESSION ABSTRACTS455. T
- Page 239 and 240:
FULL POSTER SESSION ABSTRACTSor hos
- Page 241 and 242:
FULL POSTER SESSION ABSTRACTSfragme
- Page 243 and 244:
FULL POSTER SESSION ABSTRACTSenhanc
- Page 245 and 246:
FULL POSTER SESSION ABSTRACTSassess
- Page 247 and 248:
FULL POSTER SESSION ABSTRACTSmating
- Page 249 and 250:
FULL POSTER SESSION ABSTRACTScommon
- Page 251 and 252:
FULL POSTER SESSION ABSTRACTSOne of
- Page 253 and 254:
FULL POSTER SESSION ABSTRACTScells
- Page 255 and 256:
FULL POSTER SESSION ABSTRACTSof Ave
- Page 257 and 258:
FULL POSTER SESSION ABSTRACTSascaro
- Page 259 and 260:
FULL POSTER SESSION ABSTRACTSis a n
- Page 261 and 262:
FULL POSTER SESSION ABSTRACTSand th
- Page 263 and 264:
FULL POSTER SESSION ABSTRACTSCiuffe
- Page 265 and 266:
FULL POSTER SESSION ABSTRACTSon oth
- Page 267 and 268:
FULL POSTER SESSION ABSTRACTScopies
- Page 269 and 270:
FULL POSTER SESSION ABSTRACTSChem.
- Page 271 and 272:
FULL POSTER SESSION ABSTRACTS593. C
- Page 273 and 274:
FULL POSTER SESSION ABSTRACTS601. P
- Page 275 and 276:
FULL POSTER SESSION ABSTRACTSE.elym
- Page 277 and 278:
FULL POSTER SESSION ABSTRACTSThe de
- Page 279 and 280:
FULL POSTER SESSION ABSTRACTSMicrob
- Page 281 and 282:
FULL POSTER SESSION ABSTRACTSchromo
- Page 283 and 284:
FULL POSTER SESSION ABSTRACTSmating
- Page 285 and 286:
FULL POSTER SESSION ABSTRACTSAt the
- Page 287 and 288:
FULL POSTER SESSION ABSTRACTSemerge
- Page 289 and 290:
FULL POSTER SESSION ABSTRACTS666. G
- Page 291 and 292:
FULL POSTER SESSION ABSTRACTSof che
- Page 293 and 294:
FULL POSTER SESSION ABSTRACTSthe lo
- Page 295 and 296:
FULL POSTER SESSION ABSTRACTSin the
- Page 297 and 298:
FULL POSTER SESSION ABSTRACTSpotent
- Page 299 and 300:
FULL POSTER SESSION ABSTRACTSpoint
- Page 301 and 302:
FULL POSTER SESSION ABSTRACTS716. p
- Page 303 and 304:
FULL POSTER SESSION ABSTRACTSnatura
- Page 305 and 306:
FULL POSTER SESSION ABSTRACTSelemen
- Page 307 and 308:
KEYWORD LISTABC proteins ..........
- Page 309 and 310:
KEYWORD LISThigh temperature growth
- Page 311 and 312:
AUTHOR LISTBolton, Melvin D. ......
- Page 313 and 314:
AUTHOR LISTFrancis, Martin ........
- Page 315 and 316:
AUTHOR LISTKawamoto, Susumu... 427,
- Page 317 and 318:
AUTHOR LISTNNadimi, Maryam ........
- Page 319 and 320:
AUTHOR LISTSenftleben, Dominik ....
- Page 321 and 322:
AUTHOR LISTYablonowski, Jacob .....
- Page 323 and 324:
LIST OF PARTICIPANTSLeslie G Beresf
- Page 325 and 326:
LIST OF PARTICIPANTSTim A DahlmannR
- Page 327 and 328:
LIST OF PARTICIPANTSIgor V Grigorie
- Page 329 and 330:
LIST OF PARTICIPANTSMasayuki KameiT
- Page 331 and 332:
LIST OF PARTICIPANTSGeorgiana MayUn
- Page 333 and 334:
LIST OF PARTICIPANTSNadia PontsINRA
- Page 335 and 336:
LIST OF PARTICIPANTSFrancis SmetUni
- Page 337 and 338:
LIST OF PARTICIPANTSAric E WiestUni